Azee DT 100 mg Cipla

£15.00

Azee DT 100 mg Cipla is a dispersible azithromycin tablet formulation manufactured for research applications investigating antimicrobial mechanisms and pharmaceutical dissolution studies in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Azee DT 100 mg Cipla
Azee DT 100 mg Cipla
£15.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Product Overview: Azee DT

Azee DT 100 mg Cipla is a dispersible formulation of azithromycin, a macrolide antibiotic extensively studied in antimicrobial research applications. This pharmaceutical preparation provides researchers with standardised material for examining azithromycin’s molecular mechanisms, dissolution kinetics, and pharmacological properties in controlled in-vitro environments. The dispersible tablet format enables comprehensive studies of drug release profiles and bioavailability parameters. Our Stroid UK Shop ensures reliable access to pharmaceutical-grade compounds for research institutions requiring consistent material specifications for their investigations.

Research Applications

This azithromycin formulation serves multiple research domains including antimicrobial resistance studies, pharmacokinetic modelling, and pharmaceutical technology investigations. Researchers studying azithromycin preparations can examine dissolution characteristics, tablet disintegration profiles, and comparative bioequivalence parameters. The compound’s macrolide structure provides opportunities for investigating ribosomal binding mechanisms and protein synthesis inhibition pathways. Additionally, formulation scientists can analyse excipient interactions, stability parameters, and quality control methodologies using this standardised preparation in conjunction with other research materials available through selective androgen receptor modulators and peptide research compounds.

Technical Specifications

Azee DT 100 mg Cipla Technical Data
Parameter Specification
Active Ingredient Azithromycin
Strength 100 mg per dispersible tablet
Manufacturer Cipla Limited
Formulation Type Dispersible Tablet (DT)
CAS Number 83905-01-5
Molecular Formula C₃₈H₇₂N₂O₁₂
Molecular Weight 748.98 g/mol
Storage Conditions Room temperature, dry conditions

Research Compliance Statement

This azithromycin preparation is supplied exclusively for in-vitro laboratory research purposes. The compound is intended solely for investigating antimicrobial mechanisms, pharmaceutical formulation parameters, and analytical methodology development. This product is not intended for human consumption, therapeutic use, or any diagnostic applications. Researchers must ensure compliance with institutional guidelines and applicable regulations governing antimicrobial research materials. All studies should be conducted under appropriate laboratory safety protocols with qualified scientific supervision.

Related